-
UK retirees win government pension charges victory in France
The development comes after a successful campaign from foreign residents in France and Connexion readers
-
France’s chambres d’hôtes face closure under 2026 tax and social charge changes
Measures designed to curb Airbnb-style lets are set to hit traditional B&Bs particularly hard
-
SFR customers in France warned to be vigilant following cyberattack
Data from potentially millions of customers were taken following data breach
New thyroid formula is ‘good quality’
Medicine safety agency ANSM has confirmed the ‘good quality’ of a new, controversial formula of the thyroid drug Levothyrox after doing its own analysis of it.
Levothyrox - manufactured by laboratory Merck - is the most widely-used treatment option for patients suffering from thyroid conditions, which can cause weight gain, depression, circulation problems, coldness and extreme fatigue.
The new formula has been contested by patient association l’Association Française des Malades de la Thyroïde which has reported many complaints and says it is ineffective and causes side effects including headaches and dizziness.
